French and US companies combine efforts on retinal vein occlusion-induced macular edema
Fovea Pharmaceuticals (Paris, France) and Dyax Corporation (Cambridge, Massachusetts, USA) have announced the execution of an exclusive license agreement for the development and commercialisation of… Read More »French and US companies combine efforts on retinal vein occlusion-induced macular edema